BACKGROUND: Intraoperative visualization of pancreatic tumors has the potential to improve radical resection rates. Intraoperative visualization of the common bile duct and bile duct anastomoses could be of added value. In this study, we explored the use of indocyanine green (ICG) for these applications and attempted to optimize injection timing and dose. METHODS: Eight patients undergoing a pancreaticoduodenectomy were injected intravenously with 5 or 10 mg ICG. During and after injection, the pancreas, tumor, common bile duct and surrounding organs were imaged in real time using the Mini-FLARE™ near-infrared (NIR) imaging system. RESULTS: No clear tumor-to-pancreas contrast was observed, except for incidental contrast in 1 patient. The common bile duct was clearly visualized using NIR fluorescence, within 10 min after injection, with a maximal contrast between 30 and 90 min after injection. Patency of biliary anastomoses could be visualized due to biliary excretion of ICG. CONCLUSION: No useful tumor demarcation could be visualized in pancreatic cancer patients after intravenous injection of ICG. However, the common bile duct and biliary anastomoses were clearly visualized during the observation period. Therefore, these imaging strategies could be beneficial during biliary surgery in cases where the surgical anatomy is aberrant or difficult to identify.
BACKGROUND: Intraoperative visualization of pancreatic tumors has the potential to improve radical resection rates. Intraoperative visualization of the common bile duct and bile duct anastomoses could be of added value. In this study, we explored the use of indocyanine green (ICG) for these applications and attempted to optimize injection timing and dose. METHODS: Eight patients undergoing a pancreaticoduodenectomy were injected intravenously with 5 or 10 mg ICG. During and after injection, the pancreas, tumor, common bile duct and surrounding organs were imaged in real time using the Mini-FLARE™ near-infrared (NIR) imaging system. RESULTS: No clear tumor-to-pancreas contrast was observed, except for incidental contrast in 1 patient. The common bile duct was clearly visualized using NIR fluorescence, within 10 min after injection, with a maximal contrast between 30 and 90 min after injection. Patency of biliary anastomoses could be visualized due to biliary excretion of ICG. CONCLUSION: No useful tumor demarcation could be visualized in pancreatic cancerpatients after intravenous injection of ICG. However, the common bile duct and biliary anastomoses were clearly visualized during the observation period. Therefore, these imaging strategies could be beneficial during biliary surgery in cases where the surgical anatomy is aberrant or difficult to identify.
Authors: Tao Jiang; Emilia S Olson; Quyen T Nguyen; Melinda Roy; Patricia A Jennings; Roger Y Tsien Journal: Proc Natl Acad Sci U S A Date: 2004-12-15 Impact factor: 11.205
Authors: J Sven D Mieog; Merlijn Hutteman; Joost R van der Vorst; Peter J K Kuppen; Ivo Que; Jouke Dijkstra; Eric L Kaijzel; Frans Prins; Clemens W G M Löwik; Vincent T H B M Smit; Cornelis J H van de Velde; Alexander L Vahrmeijer Journal: Breast Cancer Res Treat Date: 2010-09-07 Impact factor: 4.872
Authors: Axel Hagen; Dirk Grosenick; Rainer Macdonald; Herbert Rinneberg; Susen Burock; Peter Warnick; Alexander Poellinger; Peter M Schlag Journal: Opt Express Date: 2009-09-14 Impact factor: 3.894
Authors: John P Gleysteen; J Robert Newman; David Chhieng; Andra Frost; Kurt R Zinn; Eben L Rosenthal Journal: Head Neck Date: 2008-06 Impact factor: 3.147
Authors: Sang Bong Lee; Moinuddin Hassan; Robert Fisher; Oleg Chertov; Victor Chernomordik; Gabriela Kramer-Marek; Amir Gandjbakhche; Jacek Capala Journal: Clin Cancer Res Date: 2008-06-15 Impact factor: 12.531
Authors: Stijn Keereweer; Jeroen D F Kerrebijn; Pieter B A A van Driel; Bangwen Xie; Eric L Kaijzel; Thomas J A Snoeks; Ivo Que; Merlijn Hutteman; Joost R van der Vorst; J Sven D Mieog; Alexander L Vahrmeijer; Cornelis J H van de Velde; Robert J Baatenburg de Jong; Clemens W G M Löwik Journal: Mol Imaging Biol Date: 2011-04 Impact factor: 3.488
Authors: Alexander L Vahrmeijer; Merlijn Hutteman; Joost R van der Vorst; Cornelis J H van de Velde; John V Frangioni Journal: Nat Rev Clin Oncol Date: 2013-07-23 Impact factor: 66.675
Authors: Joost R van der Vorst; Alexander L Vahrmeijer; Merlijn Hutteman; Tjalling Bosse; Vincent T H B M Smit; Cornelis J H van de Velde; John V Frangioni; Bert A Bonsing Journal: World J Gastrointest Surg Date: 2012-07-27
Authors: Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert Journal: Nat Rev Clin Oncol Date: 2017-01-17 Impact factor: 66.675
Authors: Floris P R Verbeek; Boudewijn E Schaafsma; Quirijn R J G Tummers; Joost R van der Vorst; Wendeline J van der Made; Coen I M Baeten; Bert A Bonsing; John V Frangioni; Cornelis J H van de Velde; Alexander L Vahrmeijer; Rutger-Jan Swijnenburg Journal: Surg Endosc Date: 2014-04 Impact factor: 4.584
Authors: Mehraneh D Jafari; Kang Hong Lee; Wissam J Halabi; Steven D Mills; Joseph C Carmichael; Michael J Stamos; Alessio Pigazzi Journal: Surg Endosc Date: 2013-02-13 Impact factor: 4.584